Abstract
AbstractIn the 1970s, many people had severe hypertension and related cardiovascular and cerebrovascular diseases; however, antihypertensive treatments were not available at the time. The author encountered such conditions during the initial exposure to medicine. The author subsequently entered the field of hypertension medicine to prevent such conditions and engaged in hypertension research for more than 50 years. The author’s central interest was the physiological and clinical aspects of blood pressure (BP) variability. Out-of-clinic BP measurements were the focus of clinical research. It was anticipated that self-measurement of BP at home (HBP) would improve medical practice surrounding hypertension. To establish evidence-based hypertension medicine, the Ohasama study (an epidemiology based on HBP) was conducted. The study provided firm evidence of the clinical significance of HBP and diagnostic criteria for hypertension and normotension. To establish target HBP levels for antihypertensive therapy, the Hypertension Objective treatment based on Measurement by Electrical Devices of Blood Pressure (HOMED-BP) study (a prospective intervention study) was also conducted. Application of HBP measurements expanded to obstetric, clinical pharmacology, pathophysiology, and genetic studies. During these studies, crucial information on the clinical significance of BP variability (such as circadian and day-by-day variation of BP, nocturnal BP, white-coat hypertension, and masked hypertension) was established. Finally, the author described the priority of HBP over clinic-measured BP for the diagnosis of hypertension in the 2014 Japanese Society of Hypertension Guidelines. In this article, the author’s history of hypertension research, from the first encounter with hypertension to the construction of guidelines on hypertension, is reviewed.
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine
Reference91 articles.
1. Imai Y, Satoh K, Taira N. Role of the peripheral vasculature in changes in venous return caused by isoproterenol, norepinephrine, and methoxamine in anesthetized dogs. Circ Res. 1978;43:553–61.
2. Imai Y, Nolan PL, Johnston CI. Restoration of suppressed baroreflex sensitivity in rats with hereditary diabetes insipidus (Brattleboro rats) by arginine-vasopressin and DDAVP. Circ Res. 1983;53:140–9.
3. Imai Y, Sasaki S, Abe K, Minami N, Sekino H, Yosinaga K. Centrally-mediated hypotensive and blood pressure stabilizing effect of vasopressin in brattleboro rat. J Hypertens. 1986;4:S582–S584.
4. Imai Y, Abe K, Sasaki S, Minami N, Nobunaga T, Sekino H, et al. Hypotensive and bradycardic effects of centrally administered vasopressin in stroke-prone spontaneously hypertensive rats. Hypertension. 1987;10:346–9.
5. Imai Y, Nihei M, Abe K, Sasaki S, Minami N, Munakata M, et al. A finger volume-oscillometric device for monitoring ambulatory blood pressure: laboratory and clinical evaluations. Clin Exp Hypertens. 1987;A9:2001–25.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献